» Articles » PMID: 22507872

Mycobacterium Tuberculosis ManLAM Inhibits T-cell-receptor Signaling by Interference with ZAP-70, Lck and LAT Phosphorylation

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2012 Apr 18
PMID 22507872
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Immune evasion is required for Mycobacterium tuberculosis to survive in the face of robust CD4(+) T cell responses. We have shown previously that M. tuberculosis cell wall glycolipids, including mannose capped lipoarabinomannan (ManLAM), directly inhibit polyclonal murine CD4(+) T cell activation by blocking ZAP-70 phosphorylation. We extended these studies to antigen-specific murine CD4(+) T cells and primary human T cells and found that ManLAM inhibited them as well. Lck and LAT phosphorylation also were inhibited by ManLAM without affecting their localization to lipid rafts. Inhibition of proximal TCR signaling was temperature sensitive, suggesting that ManLAM insertion into T cell membranes was required. Thus, M. tuberculosis ManLAM inhibits antigen-specific CD4(+) T cell activation by interfering with very early events in TCR signaling through ManLAM's insertion in T cell membranes.

Citing Articles

Advancing Roles and Therapeutic Potentials of Pyroptosis in Host Immune Defenses against Tuberculosis.

Yang J, Ma Y, Yu J, Liu Y, Xia J, Kong X Biomolecules. 2024; 14(10).

PMID: 39456188 PMC: 11505957. DOI: 10.3390/biom14101255.


.

Majambere J, Zaidi S, Errami A, Marih L, Marhoum El Filali K, Bousfiha A Tunis Med. 2024; 102(8):440-446.

PMID: 39129569 PMC: 11387960. DOI: 10.62438/tunismed.v102i8.4816.


Antibodies as clinical tools for tuberculosis.

McIntyre S, Warner J, Rush C, Vanderven H Front Immunol. 2024; 14:1278947.

PMID: 38162666 PMC: 10755875. DOI: 10.3389/fimmu.2023.1278947.


Impact of Mycobacterium tuberculosis Glycolipids on the CD4+ T Cell-Macrophage Immunological Synapse.

Mwebaza I, Shaw R, Li Q, Fletcher S, Achkar J, Harding C J Immunol. 2023; 211(9):1385-1396.

PMID: 37695687 PMC: 10579150. DOI: 10.4049/jimmunol.2300107.


Clinical manifestations and immune response to tuberculosis.

Carabali-Isajar M, Rodriguez-Bejarano O, Amado T, Patarroyo M, Izquierdo M, Lutz J World J Microbiol Biotechnol. 2023; 39(8):206.

PMID: 37221438 PMC: 10205569. DOI: 10.1007/s11274-023-03636-x.


References
1.
Campi G, Varma R, Dustin M . Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med. 2005; 202(8):1031-6. PMC: 1373686. DOI: 10.1084/jem.20051182. View

2.
Gehring A, Rojas R, Canaday D, Lakey D, Harding C, Boom W . The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun. 2003; 71(8):4487-97. PMC: 166015. DOI: 10.1128/IAI.71.8.4487-4497.2003. View

3.
Shaw A . Lipid rafts: now you see them, now you don't. Nat Immunol. 2006; 7(11):1139-42. DOI: 10.1038/ni1405. View

4.
Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M . Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol. 2005; 6(12):1253-62. DOI: 10.1038/ni1272. View

5.
Wang X, Barnes P, Dobos-Elder K, Townsend J, Chung Y, Shams H . ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells. J Immunol. 2009; 182(6):3668-77. PMC: 5488288. DOI: 10.4049/jimmunol.0803579. View